Galectin-14, also known as LGALS14, is primarily expressed intracellularly in the placenta and eosinophils . Eosinophils are a type of white blood cell involved in the body’s immune response, particularly in combating parasitic infections and in allergic reactions. Upon allergen stimulation, eosinophils release Galectin-14 .
The exact biological functions of Galectin-14 are still being investigated. However, it is believed to play a role in modulating immune responses, particularly in the context of allergic reactions and inflammation . The ability of Galectin-14 to bind to β-Galactoside suggests it may be involved in cell-cell and cell-matrix interactions, which are crucial for various physiological processes .
Recombinant Galectin-14 refers to the protein produced through recombinant DNA technology, which allows for the expression of the protein in a controlled laboratory setting. This recombinant form is used in various research applications to study the protein’s structure, function, and potential therapeutic uses .